CAR-T – Page 4 – Talk Bio

Actionable Insights Powered by AI

BMS Expands CAR-T Therapy Capabilities with Strategic $380 Million Investment in Cellares

1 year ago talkbio0Tagged Automation, Biotechnology, Burning Mouth Syndrome, Cancer Therapeutic Procedure, Capacity, CAR-T, Cell Therapy, Cellares, expansion, Investments, Manufacture, squibb

BMS, Bristol Myers Squibb, Cellares, CAR-T therapy, cell therapy, cancer treatment, biotechnology, investment, capacity expansion, manufacturing, automation.

BioNTech Boosts CAR-T Manufacturing Prowess with Autolus Investment and mRNA Synergy

1 year ago talkbio0Tagged Autolus, BioNTech, CAR-T, Investments, Manufacture

BioNTech, CAR-T, Manufacture, Investments, Autolus